
Currently out of the existing stock ratings of Andrew Mok, 41 are a SELL (10.85%), 133 are a HOLD (35.19%), 204 are a BUY (53.97%).
Analyst Andrew Mok, currently employed at BARCLAYS, has had 64.26% of price targets met with an average potential upside of 16.35%, reached in 152 days on average.
Andrew Mok has documented 760 price targets and ratings displayed on 32 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on HUM, Humana.
Analyst best performing recommendations are on AGL (AGILON HEALTH).
The best stock recommendation documented was for DVA (DAVITA HEALTHCARE PARTNERS) on 2/2/2026. The price target of $143 was fulfilled within 3 days with a profit of $31.81 (28.61%), with a performance score of 95.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Feb-2023
$100
$100
1 years 7 months 1 days ago
(16-Apr-2025)
3/4 (75%)
$8.09 (8.80%)
347
Hold Since 21-Apr-2023
$101
$101
1 years 7 months 13 days ago
(04-Apr-2025)
2/9 (22.22%)
$9.11 (9.91%)
419
Hold Since 26-Mar-2024
1 years 8 months 7 days ago
(10-Mar-2025)
6/11 (54.55%)
$12.13 (9.49%)
97
Hold Since 21-Oct-2019
$101
$91
1 years 8 months 13 days ago
(04-Mar-2025)
6/13 (46.15%)
$8.9 (9.66%)
25
Buy Since 03-Aug-2018
$100
$139
1 years 10 months 18 days ago
(30-Dec-2024)
8/14 (57.14%)
$9.51 (10.51%)
89
Which stock is Andrew Mok most bullish on?
Which stock is Andrew Mok most reserved on?
What Year was the first public recommendation made by Andrew Mok?